PD-1 expression and its correlation with tumour infiltrating lymphocytes and Ki67 in patients with breast cancer

被引：0
|
作者：
Vos, Hanne
Lambein, Kathleen
Floris, Giuseppe
Nevelsteen, Ines
Smeets, Ann
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Katholieke Univ Leuven, Translat Cell & Tissue Res, Leuven, Belgium
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-15
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immunohistochemical expression of RPRM is associated with low expression of proliferation marker Ki67 in patients with breast cancer
    Buchegger, Kurt
    Lopez, Jaime
    Ili, Carmen
    Riquelme, Ismael
    Letelier, Pablo
    Guzman, Pablo
    Bellolio, Enrique
    Corvalan, Alejandro H.
    Brebi, Priscilla
    Carlos Roa, Juan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3025 - 3032
  • [32] Correlation of Ki67 expression with FDG-PET positivity in triple negative breast cancer.
    Tchou, J.
    John, T.
    Basu, S.
    Rosen, M.
    Schnall, M.
    Alavi, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S49 - S49
  • [33] Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
    A Bottini
    A Berruti
    A Bersiga
    M P Brizzi
    P Bruzzi
    S Aguggini
    A Brunelli
    G Bolsi
    G Allevi
    D Generali
    E Betri
    G Bertoli
    P Alquati
    L Dogliotti
    British Journal of Cancer, 2001, 85 : 1106 - 1112
  • [34] Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
    Bottini, A
    Berruti, A
    Bersiga, A
    Brizzi, MP
    Bruzzi, P
    Aguggini, S
    Brunelli, A
    Bolsi, A
    Bolsi, G
    Allevi, G
    Generali, D
    Betri, E
    Bertoli, G
    Alquati, P
    Dogliotti, L
    BRITISH JOURNAL OF CANCER, 2001, 85 (08) : 1106 - 1112
  • [35] THE CORRELATION OF KI67 GROWTH-FACTOR AND ERICA IN BREAST-CANCER
    HANNA, WM
    KAHN, HJ
    CHAPMAN, JAW
    MODERN PATHOLOGY, 1992, 5 (03) : 220 - 223
  • [36] Evaluation of tumour-infiltrating lymphocytes (TILS) and PD-L1 expression in breast cancer of young women
    Evangelou, Z.
    Papoudou-Bai, A.
    Kamina, S.
    Kourea, E.
    Stefanou, D.
    Batistatou, A.
    VIRCHOWS ARCHIV, 2017, 471 : S53 - S53
  • [37] Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression
    Poetzsch, M.
    Berg, E.
    Hummel, M.
    Stein, U.
    von Winterfeld, M.
    Joehrens, K.
    Rau, B.
    Daum, S.
    Treese, C.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [38] Crosstalk between programmed death ligand 1 (PD-L1) expression, Ki-67 labelling index and tumour infiltrating lymphocytes (TILs) in invasive breast cancer: a tertiary care centre study
    Sharma, R.
    Elhence, P.
    Rao, M.
    Khera, S.
    Chaudhary, R.
    Pareek, P.
    Vishnoi, J. R.
    VIRCHOWS ARCHIV, 2020, 477 : S53 - S54
  • [39] Prognostic factor Ki67 for breast cancer patients in each subgroup
    Niikura, Naoki
    Masuda, Shinobu
    Terada, Mizuho
    Terao, Mayako
    Kumaki, Nobue
    Oshitanai, Risa
    Morioka, Toru
    Tuda, Banri
    Okamura, Takuho
    Saito, Yuki
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor-Positive Breast Cancer
    Penault-Llorca, Frederique
    Andre, Fabrice
    Sagan, Christine
    Lacroix-Triki, Magali
    Denoux, Yves
    Verriele, Veronique
    Jacquemier, Jocelyne
    Baranzelli, Marie Christine
    Bibeau, Frederic
    Antoine, Martine
    Lagarde, Nicole
    Martin, Anne-Laure
    Asselain, Bernard
    Roche, Henri
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2809 - 2815
12345